PharmaShots | Incisive News in 3 Shots

Subscribe Now

TactiCath SE

Abbott Reports Results of TactiCath SE in (PERSIST-END) Study for the Treatment of Persistent Atrial Fibrillation

Abbott Reports Results of TactiCath SE in (PERSIST-END) Study for the Treatment of Persistent Atrial Fibrillation

May 2, 2022

Contact Us

First Floor, B 150, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us